Rothschild Investment LLC Adaptive Biotechnologies Corp Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 10,210 shares of ADPT stock, worth $57,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,210
Previous 10,040
1.69%
Holding current value
$57,482
Previous $36.3 Million
43.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
185Shares Held
154MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$169 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$78.8 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$65.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$65.3 Million0.56% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$65.2 Million0.32% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $804M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...